EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Berberine and Its Study as an Antidiabetic Compound

Ayudiah Rizki Utami, Iman Permana Maksum, Yusi Deawati iD

Biology · 08.07.2023 · 12 (7) · 973

DOI: 10.3390/biology12070973 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 08.07.2023. Verfasst von Ayudiah Rizki Utami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang 45363, Indonesia. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Padjadjaran University, Riset Data Pustaka dan Daring (RDPD) 2023.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) is a metabolic disorder that causes hyperglycemia conditions and leads to various chronic complications that causes death. The prevalence of diabetes is predicted to continue to increase, and with the high toxicity levels of current diabetes drugs, the exploration of natural compounds as alternative diabetes treatment has been widely carried out, one of which is berberine. Berberine and several other alkaloid compounds, including some of its derivatives, have shown many bioactivities, such as neuraminidase and hepatoprotective activity. Berberine also exhibits antidiabetic activity. As an antidiabetic compound, berberine is known to reduce blood glucose levels, increase insulin secretion, and weaken glucose tolerance and insulin resistance by activating the AMPK pathway. Apart from being an antidiabetic compound, berberine also exhibits various other activities such as being anti-adipogenic, anti-hyperlipidemic, anti-inflammatory, and antioxidant. Many studies have been conducted on berberine, but its exact mechanism still needs to be clarified and requires further investigation. This review will discuss berberine and its mechanism as a natural compound with various activities, mainly as an antidiabetic.

Schlagwörter

Stichwörter der Autor:innen

AMPK pathwayantidiabetic compounddiabetes mellitushyperglycemia

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang 45363, Indonesia.

ORCID-Profile: Yusi Deawati

Förderung

  • Padjadjaran University
  • Riset Data Pustaka dan Daring (RDPD) 2023

Zitieren

APA

Utami, A. R., Maksum, I. P., & Deawati, Y. (2023). Berberine and Its Study as an Antidiabetic Compound. Biology, 12(7), 973. https://doi.org/10.3390/biology12070973

Vancouver

Utami AR, Maksum IP, Deawati Y. Berberine and Its Study as an Antidiabetic Compound. Biology. 2023;12(7):973. doi:10.3390/biology12070973

BibTeX
@article{Utami2023,
  author = {Utami, Ayudiah Rizki and Maksum, Iman Permana and Deawati, Yusi},
  title = {Berberine and Its Study as an Antidiabetic Compound},
  journal = {Biology},
  year = {2023},
  volume = {12},
  number = {7},
  pages = {973},
  doi = {10.3390/biology12070973}
}
Kostenlos starten →